
GulfBio · GB-RETATRUTIDE-10MG
Retatrutide 10mg
Taxes included. Shipping calculated at checkout.
Prices are set in USD. Local-currency amounts are indicative conversions for guidance only.
Shipped in discreet, unbranded packaging — no company name or product description on the outer box.
In stock
Quantity (0 in cart)
Description
A potent triple-receptor agonist (GLP-1, GIP, and Glucagon) supplied as a 10mg lyophilised powder for metabolic research applications.
Retatrutide 10mg is a triple-agonist peptide currently at the forefront of metabolic research. This synthetic peptide acts simultaneously on three different receptors: the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon (GCG) receptors. By engaging this triad of metabolic pathways, Retatrutide represents a significant evolution in the study of incretin mimetics, offering researchers a multifaceted tool for investigating complex endocrine interactions. In laboratory environments, this compound is primarily utilised to observe the synergistic effects of multi-receptor activation on metabolic rate and energy homeostasis. Its unique structure, derived from the GIP sequence, has been engineered to provide high potency across all three target receptors, making it a critical subject for studies focusing on hormonal regulation and physiological feedback loops. GulfBio provides this peptide in a highly purified, lyophilised form to ensure stability and reproducibility in all in vitro and in vivo research settings.
Product Overview
Retatrutide 10mg is a research-grade peptide designed for laboratory investigations. As a triple agonist, it allows for the examination of biochemical pathways involving GLP-1, GIP, and Glucagon receptors. This product is intended strictly for scientific research purposes and is not for human or animal consumption.
Specifications
Form: Lyophilised Powder Quantity: 10mg per vial Purity: ≥99% as determined by HPLC analysis Molecular Formula: C221H342N54O68 Storage: Store in a cool, dry place, protected from direct light. For long-term stability, store at -20°C.
Research Applications
Research involving Retatrutide focuses largely on its influence over glucose metabolism, lipid profile modulation, and energy expenditure. Because it activates the glucagon receptor in addition to the traditional GLP-1 and GIP pathways, it is frequently studied for its potential to affect hepatic glucose production and thermogenesis in research models. Scientists use this compound to map the specific contributions of each receptor pathway to overall metabolic efficiency.
Certificate of Analysis
Review the batch documentation for identity and purity details.
COAs available upon request — contact GulfBio Support.
Research Use Notice
For laboratory research use only. Not for human or veterinary use.
Related items

Vials
Retatrutide 15mg
A potent 15mg triple agonist peptide (GLP-1, GIP, and GCG) designed for advanced metabolic and endocrine research applications.

Vials
Retatrutide 20mg
A potent triple-hormone agonist (GLP-1/GIP/GCG) provided in a 20mg vial for advanced metabolic and biochemical research.

Vials
Tesamorelin 10mg
A synthetic 44-amino acid analogue of Growth Hormone-Releasing Factor (GRF) designed for research into growth hormone secretion and lipid metabolism.
